124 The dual GLP-1/GIP receptor agonist tirzepatide ameliorated AD pathology in diabetic rat models by improving learning and memory, modulating cerebral glucose metabolism, promoting neurotrophic factor expression, and suppressing inflammatory responses
Current models of APC action emphasize its role as a component of DCs to promote -catenin degradation
Brahm H, Piehl-Aulin K, Saltin B, Ljunghall S
The GLP-1 Market: A Booming Opportunity: GLP-1-based therapies have emerged as promising treatments for obesity and diabetes, offering significant weight loss benefits and improved glycemic control
Liraglutide reduces visceral and intrahepatic fat without significant loss of muscle mass in obese patients with type 2 diabetes: a prospective case series
In addition to their glycemic effects, DPP-4 inhibitors have the potential to decrease bone resorption, increase bone formation, and reduce the incidence of osteoporosis and fractures